This past week was a bit rough on the overall markets as on Tuesday, the markets seemed to bet on a Romney win, only to sell off the next day on news of an Obama win.
The good news for biotech from President Obama's reelection is that his policies are biotech friendly, especially towards smaller cap developmental biotechs, especially those who are working on orphan drug "unmet need" treatments and potential cures.
Take a listen to the following video I made which I mention stocks as $PSTI, $CPRX, $AEGR, $VRNG, $BSDM, and others. I also offer additional insight and market commentary.
Scott
